Diagnosis, classification and treatment of gestational trophoblastic neoplasia

被引：34

作者：

Biscaro, Andressa ^{[1
]}

Braga, Antonio ^{[2
,3
]}

Berkowitz, Ross Stuart ^{[4
,5
]}

机构：

[1] Univ Fed Fluminense, Maternal & Child Hlth, Rio De Janeiro, RJ, Brazil

[2] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil

[3] Univ Fed Fluminense, Rio De Janeiro, RJ, Brazil

[4] Harvard Med Sch, Dept Obstet Gynecol & Reprod Biol, Boston, MA USA

[5] Brigham & Womens Hosp, Harvard Med Sch, Boston, MA USA

来源：

REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2015年 / 37卷 / 01期

关键词：

Gestational trophoblastic disease/diagnosis; Gestational trophoblastic disease/classification; Gestational trophoblastic disease/drug therapy; Choriocarcinoma/drug therapy;

D O I：

10.1590/SO100-720320140005198

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Gestational trophoblastic neoplasia (GTN) is the term to describe a set of malignant placental diseases, including invasive mole, choriocarcinoma, placental site trophoblastic tumor and epithelioid trophoblastic tumor. Both invasive mole and choriocarcinoma respond well to chemotherapy, and cure rates are greater than 90%. Since the advent of chemotherapy, low-risk GTN has been treated with a single agent, usually methotrexate or actinomycin D. Cases of high-risk GTN, however, should be treated with multiagent chemotherapy, and the regimen usually selected is EMA-CO, which combines etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine. This study reviews the literature about GTN to discuss current knowledge about its diagnosis and treatment.

引用

页码：42 / 51

页数：10

共 52 条

[21] Gestatational Trophoblastic Disease: Multimodality Imaging Assessment With Special Emphasis on Spectrum of Abnormalities and Value of Imaging in Staging and Management of Disease
Kani, Kimia Khalatbari
Lee, Jean H.
Dighe, Manjiri
Moshiri, Mariam
Kolokythas, Orpheus
Dubinsky, Theodore
[J]. CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2012, 41 (01) : 1 - 10
[22] Persistence and malignant sequelae of gestational trophoblastic disease: Clinical presentation, diagnosis, treatment and outcome
Khoo, Soo-Keat
Sidhu, Mukhtiar
Baartz, David
Yip, Wai-Lum
Tripcony, Lee
[J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2010, 50 (01) : 81 - 86
[23] Kohorn EI, 2014, J REPROD MED, V59, P145
[24] Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia A Randomized Controlled Trial
Lertkhachonsuk, Arb-aroon
Israngura, Nathpong
Wilailak, Sarikapan
Tangtrakul, Somsak
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 985 - 988
[25] Lurain JR, 2012, J REPROD MED, V57, P219
[26] Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia
Lurain, John R.
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (01) : 11 - 18
[27] Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole
Lurain, John R.
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (06) : 531 - 539
[28] Secondary chemotherapy for high-risk gestational trophoblastic neoplasia
Lurain, JR
Nejad, B
[J]. GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 618 - 623
[29] Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy
Lybol, C.
Westerdijk, K.
Sweep, F. C. G. J.
Ottevanger, P. B.
Massuger, L. F. A. G.
Thomas, C. M. G.
[J]. ANNALS OF ONCOLOGY, 2012, 23 (11) : 2903 - 2906
[30] Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
Lybol, C.
Sweep, F. C. G. J.
Harvey, R.
Mitchell, H.
Short, D.
Thomas, C. M. G.
Ottevanger, P. B.
Savage, P. M.
Massuger, L. F. A. G.
Seckl, M. J.
[J]. GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 576 - 579

← 1 2 3 4 5 6 →